B Evidence Grade B Graded accuracy verified by the review judge Safe to Cite Dated

203

203 -- media coverage pieces for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) (2015)

2015  · Aurora Communications

203 pieces of UK media coverage were generated for the UK launch campaign.

Cite this stat Share How we verify
Attribution: Aurora Communications View source
Lighthouse Research Team
Last verified:  ·  How we verify data →
Graded Evidence graded

Questions about this data

What is the media coverage pieces for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign)?

The media coverage pieces for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) is 203 as of 2015 according to Aurora Communications. This figure is the primary benchmark in the Lighthouse dataset for this segment. Individual results vary by region, channel mix, and audience quality.

What is a good media coverage pieces benchmark for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign)?

A strong media coverage pieces benchmark for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) is 203, using the current serving value as of 2015. This is one serving-eligible observation, not a distribution median; top-quartile comparisons require the underlying distribution. Vertical, audience size, and campaign type all shift what 'good' means.

How does UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) media coverage pieces compare to the industry average?

The published media coverage pieces serving value for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) is 203 as of 2015. Individual sectors and audiences may differ substantially; this single observation does not establish an aggregate mean. Quartile comparisons require the underlying distribution, which is not implied by this record.

What factors affect media coverage pieces for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign)?

Primary drivers of media coverage pieces variation for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign) include audience segmentation, timing, and channel selection. Methodology documents campaign factors, but this serving record does not quantify the effect of personalization. The current serving value is 203 as of 2015.

What media coverage pieces should I aim for as a digital marketer in 2015?

For a digital marketer, the published media coverage pieces serving value is 203; it is an evidence-grade reference, not a personalized target as of 2015. Any performance goal should account for channel mix and audience. Review the methodology before operational decisions; a gap from this serving value does not by itself indicate a structural issue.

Value
203
Unit
Count
Data Vintage
2015
Entity
UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign)
B
Strong, reliable evidence

Approved for serving with evidence grade B. The record passes the documented quality and serving gates; consult the methodology for provenance details.

61/100 confidence

Single source - not yet corroborated

Extraction
75
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Aurora Communications Primary Tier B
http://www.auroracomms.com/case-studys/sustaining-interest-in-the-uk-launch-of-a-multiple-sclerosis-… ↗
Confidence: 53/100 Vintage: 2015 Channel: Wayback
Source Article
Sustaining interest in the UK launch of a medicine - Aurora
Sustaining interest in the UK launch of a medicine The challenge: Following widespread media coverage of phase III data and European regulatory status updates relating to their new medicine, plus the news that a competitor treatment has been rejected just weeks before, a blue chip pharmaceutical com…
Original Research
Aurora Communications · Original study ↗

PR agency case study reporting campaign results

Methodology documented
Industryhealthcare
Plain Text
UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign): 203 media coverage pieces. Source: Aurora Communications (2015). Via Lighthouse Intelligence -- https://lighthousedata.io/data/uk-ms-medicine-launch-media-coverage-pieces
HTML Embed
<blockquote cite="https://lighthousedata.io/data/uk-ms-medicine-launch-media-coverage-pieces" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>203</strong> -- media coverage pieces for UK launch of a multiple sclerosis medicine (Aurora pharmaceutical PR campaign)<br><small>Source: Aurora Communications (2015) · <a href="https://lighthousedata.io/data/uk-ms-medicine-launch-media-coverage-pieces" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Share on X Share on LinkedIn

Use this data in your work

Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.

Copy citation Explore similar stats →